Breaking Finance News

Maxim Group reported on Soleno Therapeutics (NASDAQ:SLNO), dropping its stock price target to $8.00 today

Yesterday Soleno Therapeutics (NASDAQ:SLNO) traded 0.00% even at $1.93. Soleno Therapeutics’s 50-day average is $0.00 and its two hundred day average is $0.00. The last stock price is up 0.00% from the 200-day average, compared with the S&P 500 Index which has increased 0.02% over the date range. Trading volume held steady, with 0 shares of SLNO changing hands on par with the typical 0

Maxim Group dropped the price target of Soleno Therapeutics (NASDAQ:SLNO) to $8.00 indicating a possible upside of 3.15%.

See Chart Below

Soleno Therapeutics (NASDAQ:SLNO)

Soleno Therapeutics has with a one year low of $0.00 and a one year high of $0.00 and has a total market value of $0.

More About Soleno Therapeutics (NASDAQ:SLNO)

Soleno Therapeutics, Inc., formerly Capnia, Inc., is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief. The Company has developed the CoSense End-Tidal Carbon Monoxide Monitor that measures ETCO for the detection of dangerous hemolysis rates. The Infant Solutions product line, including the NeoPIP Infant Resuscitator Unit and accessories, is designed for controlled and accurate resuscitation of neonates and infants in the clinical environment. Serenz Nasal Relief is a hand-held nasal irrigator that uses carbon dioxide (CO2) gas to wash the nasal passages.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.